MedPath

The effect of androgen administration on IVF outcome in poor responders

Phase 3
Conditions
Patient with poor responder ovareis.
Female infertility
Registration Number
IRCT20180818040828N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patient with poor responder ovaries
Age <45 years
Age >18 years

Exclusion Criteria

Sever Endomtriosis
Sever Male Factor
Uncontrol Endocrine Disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 5 Week after embryo transfer. Method of measurement: Vaginal Sonography to see fetus in gestational sac.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Check BHCG.;Fetus number. Timepoint: 2-3 day after follicle aspiration. Method of measurement: Fetus in labratory.;Oocyte number. Timepoint: In follicular aspiration day. Method of measurement: To see oocytes in labratory.;The number of dominant follicle. Timepoint: In ovulation stimulation cycle. Method of measurement: Vaginal sonography.;Estradiol level in blood. Timepoint: To see 2-3number of >=17 mm follicle. Method of measurement: Check in labratoty.;Gonadotropin dosage. Timepoint: At the end of ovarian stimulation. Method of measurement: International Units.
© Copyright 2025. All Rights Reserved by MedPath